Trimel Pharma's sexual disorder drug effective in mid-stage study
(Reuters) - Trimel Pharmaceuticals Corp said its experimental sexual disorder drug increased the average number of orgasms in patients with Female Orgasmic Disorder in a mid-stage study.
No comments:
Post a Comment